Adalimumab for non-infectious uveitis: is it cost-effective?
Br J Ophthalmol
; 103(11): 1633-1638, 2019 11.
Article
in En
| MEDLINE
| ID: mdl-30728124
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uveitis
/
Cost-Benefit Analysis
/
Antirheumatic Agents
/
Adalimumab
Type of study:
Clinical_trials
/
Health_economic_evaluation
Aspects:
Patient_preference
Limits:
Adult
/
Female
/
Humans
/
Male
Country/Region as subject:
Europa
Language:
En
Journal:
Br J Ophthalmol
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: